Filter posts

Patient and Health Advocacy Summit: Ensuring Patient Access and Affordability

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access …

It Starts with One—Presentation at BIO 2018 Leads to International Agreement

A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation …

Opportunities for Patient and Health Advocates

Last week, the seventh annual Patient and Health Advocacy Summit brought  hundreds of patient advocates, …

BIO Patient & Health Advocacy Summit Concludes Today

Each year BIO brings the patient stakeholder community together for the BIO Patient and Health …

Making SMA Newborn Screening a Reality: Collaborating with the Patient Advocacy Community

Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, …

2018 BIO Investor Forum Wraps Up

As the stock market continued its volatile swings this week, investors at the BIO Investor …

BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

Within the past year, the FDA has launched a provider pre-certification program as a pilot …

A Patient-Centric Approach to Investing & Partnering

Thursday’s Plenary Luncheon Fireside Chat at the 2018 BIO Investor Forum (BIF) featured two industry leaders: …

Lessons from “View from the Board: Responding to an Acquisition Offer”

The “View from the Board: Responding to an Acquisition Offer” panel at the 2018 BIO …

On Track for a Record Breaking 2018 – #BIF18 Opening Plenary

Despite some recent market volatility, the industry is well positioned for long-term growth and success. …